Skip to main content

Published locations for Canagliflozin effects include weight loss in phase III placebo-controlled trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Canagliflozin effects include weight loss in phase III placebo-controlled trial

User login

  • Reset your password
  • /content/canagliflozin-effects-include-weight-loss-phase-iii-placebo-controlled-trial
  • /familypracticenews/article/82378/diabetes/canagliflozin-effects-include-weight-loss-phase-iii
  • /internalmedicinenews/article/82378/diabetes/canagliflozin-effects-include-weight-loss-phase-iii
  • /clinicalendocrinologynews/article/82378/diabetes/canagliflozin-effects-include-weight-loss-phase-iii
  • /endocrinology/article/82378/diabetes/canagliflozin-effects-include-weight-loss-phase-iii-placebo
  • /internalmedicine/article/82378/diabetes/canagliflozin-effects-include-weight-loss-phase-iii-placebo
  • /familymedicine/article/82378/diabetes/canagliflozin-effects-include-weight-loss-phase-iii-placebo
  • /type-2-diabetes-icymi/article/82378/diabetes/canagliflozin-effects-include-weight-loss-phase-iii